PMID: 11328764May 1, 2001Paper

Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases

The Journal of Antimicrobial Chemotherapy
C C Randegger, H Hächler

Abstract

Three amino acid substitutions, Met-69-->Ile, Arg-244-->Ser and/or Asn-276-->Asp, mediate inhibitor resistance (IR) in TEM beta-lactamases. They were introduced in all possible combinations at homologous positions into either SHV-1 or the respective extended-spectrum beta-lactamases (ESBLs), SHV-2 or SHV-5. Susceptibility testing of the resulting set of seven variants of each parental strain, all in an isogenic background, was performed. The phenotypes of the constructions revealed that most substitutions resulted in reduced resistance to most tested single beta-lactam formulations. This decrease over-compensated for the expected increase in inhibitor resistance, so that most mutants showed no rise in resistance to inhibitor/beta-lactam combinations, although increases of MICs from one- to 43-fold compared with the respective parental strains were also measured. Combination of several IR-determining substitutions impaired both phenotypes in the carrier strains even more. None of the 14 mutants derived from the ESBLs, SHV-2 and SHV-5, showed a clinically relevant combined ESBL-IR phenotype. These findings indicate that the SHV beta-lactamase does not benefit proportionally from simultaneous substitution of residues relevant for ...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·G A Jacoby, A A Medeiros
Jan 1, 1989·The Journal of Antimicrobial Chemotherapy·J W PageS W Elson
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·A PhilipponG Jacoby
Jun 5, 1983·Journal of Molecular Biology·D Hanahan
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Jan 1, 1995·The Journal of Antimicrobial Chemotherapy·S K Du BoisS G Amyes
Jun 1, 1995·Journal of Medical Microbiology·C J Thomson, S G Amyes
May 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M T Nüesch-InderbinenF H Kayser
Dec 1, 1995·The Journal of Antimicrobial Chemotherapy·P J WuI Phillips
Apr 1, 1997·Antimicrobial Agents and Chemotherapy·E E PrinarakisL S Tzouvelekis
Sep 26, 1997·Antimicrobial Agents and Chemotherapy·R A BonomoD M Shlaes
Nov 26, 1997·Antimicrobial Agents and Chemotherapy·L BretJ Sirot
Nov 20, 1998·The Journal of Infection·F M MacKenzie, I M Gould
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L PirothM Vincent-Martin
Nov 14, 1998·Current Opinion in Hematology·D A Margolis, B M Cammita
Nov 18, 1998·The Journal of Antimicrobial Chemotherapy·S G Amyes, R S Miles
Feb 18, 1999·JAMA : the Journal of the American Medical Association·J Fierer, D Guiney
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·E B ChaïbiR Labia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.